Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16782930 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1;   Drug: Cisplatin;   Drug: Oxaliplatin
2 Completed Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer
Condition: Advanced Gastric Cancer
Interventions: Drug: Chemotherapy;   Other: Best supportive care
3 Recruiting Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer
Condition: Gastric Cancer
Intervention: Biological: OTSGC-A24

Indicates status has not been verified in more than two years